Old Web
English
Sign In
Acemap
>
authorDetail
>
Joseph Jorssen
Joseph Jorssen
Immunology
Asthma
Chemistry
Mepolizumab
Medicine
4
Papers
13
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Loss of tRNA-modifying enzyme Elp3 activates a p53-dependent antitumor checkpoint in hematopoiesis.
2021
Journal of Experimental Medicine
Adeline Rosu
Najla El-Hachem
Francesca Rapino
Kevin Rouault-Pierre
Joseph Jorssen
Joan Somja
Eve Ramery
Marc Thiry
Laurent Nguyen
Maarten Jacquemyn
Dirk Daelemans
Christopher M. Adams
Dominique Bonnet
Alain Chariot
Pierre Close
Fabrice Bureau
Christophe Desmet
Show All
Source
Cite
Save
Citations (1)
Late Breaking Abstract - Anti-IL-5 mepolizumab minimally influences residual blood eosinophils in severe asthma
2021
European Respiratory Journal
Glenn van Hulst
Joseph Jorssen
Nathalie Jacobs
Monique Henket
Renaud Louis
FLorence Schleich
Fabrice Bureau
Christophe Desmet
Show All
Source
Cite
Save
Citations (0)
Anti-IL-5 mepolizumab minimally influences residual blood eosinophils in severe asthma.
2021
European Respiratory Journal
Glenn van Hulst
Joseph Jorssen
Nathalie Jacobs
Monique Henket
Renaud Louis
FLorence Schleich
Fabrice Bureau
Christophe Desmet
Show All
Source
Cite
Save
Citations (2)
Eosinophil diversity in asthma.
2020
Biochemical Pharmacology
Glenn van Hulst
Hashini M. Batugedara
Joseph Jorssen
Renaud Louis
Fabrice Bureau
Christophe Desmet
Show All
Source
Cite
Save
Citations (10)
1